Equirus Securities recommends a long position on Apollo Hospitals, targeting ₹9,444 with strong revenue growth projections through FY28.

Apollo Hospitals reported strong Q4 FY26 results: consolidated PAT surged 36% YoY to Rs 529 crore, and revenue increased 18% to Rs 6,605 crore. EBITDA grew 31% to Rs 1,011 crore.…

Apollo Hospitals announced robust financial results for the fourth quarter and the full fiscal year 2026. Consolidated revenue and net profit saw significant year-on-year…

Equirus Securities recommends a long position on Apollo Hospitals, targeting ₹9,444 with strong revenue growth projections through FY28.